Compare BioNTech SE - ADR (BNTX) vs MobilEye Global Inc (MBLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs MobilEye Global Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while MobilEye Global Inc trades at $8.96 (market cap $7.54B). The key difference: BioNTech SE - ADR is far larger — about 3.1× MobilEye Global Inc's market cap. Which is the better fit depends on your goals.
| BNTX | MBLY | |
|---|---|---|
Market Cap | $23.31B | $7.54B |
Sector | Health | Technology |
52-Week High | $119.34 | $15.54 |
52-Week Low | $83.89 | $6.56 |
Enterprise Value | $6.60B | $6.10B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →
